Caris Life Sciences, Inc. balance sheet

At the end of fiscal 2025, Caris Life Sciences, Inc. had total assets of $1.13bn, total liabilities of $548m and shareholders' equity of $577m. It held $796m in cash against $379m of debt: net cash of $417m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Caris Life Sciences, Inc.: balance sheet, annual
Fiscal year	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	—	64	796	—
Receivables	—	88	112	117
Total current assets	—	216	998	1,058
Goodwill	—	19	19	19
Total assets	—	344	1,126	1,230
Accounts payable	—	28	39	86
Deferred revenue (current)	—	7	24	21
Total current liabilities	—	165	127	191
Short-term debt	—	60	0	0
Long-term debt	—	319	379	393
Total debt	—	380	379	393
Total liabilities	—	621	548	638
Shareholders' equity	−2,145	−2,499	577	592
Non-controlling interests and other (assets − liabilities − equity)	—	2,222	—	—
Net debt (negative = net cash)	—	316	−417	—
Shares outstanding	—	183m	—	283m

US$ millions unless shown otherwise. Fiscal quarters.

Caris Life Sciences, Inc.: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	—	88	—	51	27	112	91	117
Total current assets	—	216	—	833	854	998	1,014	1,058
Goodwill	—	19	—	19	19	19	19	19
Total assets	—	344	—	955	985	1,126	1,162	1,230
Accounts payable	—	28	—	29	29	39	70	86
Deferred revenue (current)	—	7	—	5	3	24	25	21
Total current liabilities	—	165	—	90	86	127	144	191
Short-term debt	—	60	—	0	0	0	0	0
Long-term debt	—	319	—	374	376	379	381	393
Total debt	—	380	—	374	376	379	382	393
Total liabilities	—	621	—	502	506	548	569	638
Shareholders' equity	−2,442	−2,499	−2,600	453	478	577	593	592
Non-controlling interests and other (assets − liabilities − equity)	—	2,222	—	—	—	—	—	—
Shares outstanding	—	37m	—	281m	282m	283m	283m	283m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CAI vs INNV CAI vs CRVL CAI vs PNTG

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Caris Life Sciences, Inc.'s SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Caris Life Sciences, Inc.